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An investigation of the antibacterial and antifungal
activity of Myrothamnus flabellifolius against eleven dif-
ferent pathogens showed inhibition of all micro-organ-
isms except for Salmonella typhimurium and Alternaria
alternata. A preliminary screening was done by the disc
diffusion method and three susceptible organisms were
selected to demonstrate the rapid onset of antimicrobial
activity using time-kill methodology. Essential oil con-
centrations, ranging from 0.0625% to 2%, exhibited
strong fungicidal activity against Candida albicans and
were found to be bacteriostatic against Staphylococcus
aureus with microbiocidal effects increasing in a con-
centration-dependant manner. Essential oil rapidly
reduced viable counts of Pseudomonas aeruginosa but
regrowth was noted after 24 hours. The results have
been generated in duplicate in two separate microbiolo-
gy laboratories using different time-kill methods and the
results are in agreement. Eighty-five compounds were
identified by GC-MS in the hydro-distilled essential oils
which contained pinocarvone and trans-pinocarveol as
the major terpenoids. The antimicrobial properties of
the essential oil are presented as a possible rationale
for the traditional use of the resurrection bush,
Myrothamnus flabellifolius in African herbal medicinal
preparations.
Myrothamnus flabellifolius (Myrothamnaceae) is a woody
shrub about 0.4m in height with a wide distribution in south-
ern Africa. The plants have an affinity for rocky areas and
are usually wedged into crevices of large boulders. The
small aromatic leaves are fan-shaped and conspicuously
toothed on the upper leaf margin. The most remarkable fea-
ture of the plant is that the leaves fold up when desiccated.
In the rainy season the seemingly dead plants are revived
from the dry state. This unique feature is reflected in the
English (resurrection bush) and Zulu (uvukwabafile) vernac-
ular names and is used as a symbol of hope in traditional
African psychological treatment against severe depression
(Credo Mutwa, pers. comm. to B-EVW).
The leaves and twigs are used in many medicinal prepa-
rations and some of the traditional uses are summarised
from Van Wyk et al. (1997) and Hutchings et al. (1996).
Infusions are drunk for colds and respiratory ailments, nose-
bleeds and fainting. Decoctions are taken orally to alleviate
backache, kidney problems, haemorrhoids and menstrual
pains. Externally the plant may be used to treat abrasions
and the dried powdered leaves are used in dressings for
burns and wounds. The plants may be burnt and the smoke
inhaled to treat chest pains and asthma. The smoke may
also be directed into the vagina to treat infections and pains
in the uterus. The Pedi smoke the leaves in pipes to allevi-
ate chest pains and the Karanga chew the aromatic leaves
for mouth complaints. In central Africa the plant is used as a
tonic and to treat breast complaints. Shona healers have
used the plant to treat epilepsy, madness and coughs.
Numerous other uses, mostly related to colds, flu, chest
complaints and wound healing are recorded by Neuwinger
(2000) and Von Koenen (2001).
The major compounds in the essential oil of Myrothamnus
flabellifolious have been reported by Da Cunha (1974), not-
ing carvone and perillic acid as the major constituents.
Gibbs (1974) recorded the presence of 1,8-cineole and
diosphenol. The essential oil composition was recently pub-
lished by Chagonda et al. (1999) who identified 43 com-
pounds with trans-pinocarveol (28.7–28.8%), pinocarvone
(13.4–21.3 %), α-pinene (tr-23.0 %) and β-selinene (5–9.9
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%) being major constituents. Due to the conflicting reports
on the composition of the essential oils distilled from
Myrothamnus flabellifolious, we decided to re-examine the
oil composition using GC-MS as well as the antimicrobial
properties by disc diffusion and time-kill methods.
Material and Methods
Essential oil analysis
The aerial parts of three separate plants were collected in
the growing season (February 2001) from plants growing
near Klipriviersberg, Johannesburg, South Africa. The plant
material was hydro-distilled for three hours in a Clevenger
apparatus and analytical GC analysis was performed on a
Shimadzu 17A gas chromatograph using the following
parameters: Column: J&W-DB1 (30m x 0.25mm id., 0.25μm
film thickness), Temperatures: injection port 230°C, column
60°C for 1min, 5°C min-1 to 180°C, 180°C for 2min, (total =
25min). These results indicated no qualitative and negligible
quantitative variation within a population. Due to this chemi-
cal invariability and the large amounts of oil required for the
antimicrobial testing (especially time-kill studies) the oil
obtained from each of the three plants were pooled and
analysed with GC-MS operating under the following condi-
tions; Column: HP-Innowax (60m x 0.25mm id., 0.25μm film
thickness), Temperatures: injection port 250°C, column 60°C
for 10min, 4°C min-1 to 220°C, 220°C for 10min, 1°C min-1 to
240°C (total = 80min).
Antimicrobial testing
Disc diffusion assays were performed on the hydrodistilled
oils. Reference bacterial strains included in the study were
Pseudomonas aeruginosa (ATCC 33584), Escherichia coli
(ATCC 22922), Staphylococcus aureus (ATCC 25923),
Enterococcus faecalis (ATCC 29212), Serratia odorifera
(ATCC 33132), Proteus vulgaris, Salmonella typhimuium
(ATCC 14028). Reference fungal strains Candida albicans
(ATCC 10231), Cryptococcus neoformans (ATCC 90112),
Aspergillus niger (clinical strain) and Alternaria alternata
(clinical strain) were tested. Base layers of Mueller Hinton
(Oxoid) agar were prepared for bacterial studies and
Sabouroud’s Dextrose Soya (Oxoid) agar were prepared for
fungal cultures. Spore suspensions yielding an inoculum
size of 1 X 106 thoroughly mixed into the overlaying agar sur-
face. With aseptic manipulation, 6mm discs were saturated
with the pure oil (ca. 6.5mg) and placed on the set agar.
Neomycin discs (30μg, Oxoid) were used for positive bacte-
rial controls. Nystatin discs (100 iμ, Oxoid) were used for
positive fungal controls. All plates were incubated at 37°C for
48hr with the exception of the two moulds A. niger and A.
alternata which were incubated at 25°C for seven days.
Death kinetic assays were performed on S. aureus (3
strains), C. albicans (2 strains) and P. aeruginosa (1 strain).
For S. aureus (ATCC 25923) and C. albicans (ATCC 10231)
the time-kill study was carried out in two separate laborato-
ries using different time-kill methodologies. At the University
of the Witwatersrand (hereafter referred to as the UW
method), cultures were grown in Tryptone Soya (Oxoid)
broth and centrifuged for 10min at 5 000rpm. The super-
natant was discarded and the pellets resuspended in 10mL
of a 0.9% NaCl solution. Oil concentrations of 0.125, 0.25,
0.5, 1 and 2% (v/v) were incorporated into 50ml Tryptone
soya (Oxoid) broth with 0.5% Tween and a final inoculum of
approximately 1 x 106CFU ml-1. The different concentrations
were incubated at 37°C in a shaking water bath. At time
intervals ranging from 0min–24hrs, aliquots of 1ml were
transferred to 9ml inactivation broth consisting of 0.1% pep-
tone (Oxoid), 5% lecithin (Merck) and yeast extract (Oxoid).
Five serial dilutions were performed in 0.9% NaCl solution,
from the inactivation broth 100μl was plated onto Tryptone
soya (Oxoid) agar for each oil concentration. The plates
were incubated at 37°C for 48hr and colony forming units
(CFU’s) counted and death kinetics expressed in log10
reduction time-kill plots. Controls were included in the study
having the same broth formulation but without the oil. The
assay was performed in triplicate.
At the University of Iowa (hereafter referred to as the UI
method), time-kill procedures were conducted as described
previously by Klepser et al. (1997). Fungi and bacteria were
obtained from stored samples and subcultured twice on
Potato Dextrose agar or Meuller Hinton agar (Remel) prior to
testing. Suspensions containing test organisms were pre-
pared in sterile water for fungi and normal saline for bacteria
by touching three to five colonies from a 24h old culture plate
and adjusting the resulting suspension to approximately 1 x
106 to 5 x 106CFU ml-1 using spectrophotometric methods.
One milliliter of the suspension containing the test organism,
along with 0.05ml Tween 80 was added to 9ml of media,
RPMI 1640 buffered with MOPS to pH 7.0 for fungi and
Mueller Hinton broth for bacteria with or without drug, pro-
viding the starting inoculum of approximately 5 x 105CFU/ml.
The range of concentrations tested was 0.0625, 0.125, 0.25,
0.5 and 1% (v/v) oil. The culture vials were incubated with
agitation at 35°C. At predetermined time points (0, 2, 4, 6, 8,
and 24h following the addition of oil), a 0.1ml sample was
removed from each culture vial, serially diluted 1:10 in ster-
ile water or saline and a 30ml aliquot was plated on Potato
Dextrose or Mueller Hinton agar (Remel). Colony counts
were determined after incubation of the plates at 35°C for 24
to 48h. When colony counts were suspected to be less than
1 000CFU/ml, 30ml samples were removed and plated with-
out dilution. The limit of quantification by these methods is
100CFU/ml (Klepser et al. 1998a). The carryover effect of
the oil was evaluated over the range of concentrations used
in this study as previously described (Klepser et al. 1998a).
All time-kill curve experiments were conducted in duplicate.
Results and Discussion
Table 1 lists the zones (mm) showing the antimicrobial activ-
ity for all the test organisms screened. With the exception of
S. typhimurium and A. alternata the essential oil exhibited
microbial activity against all the pathogens tested.
The death kinetics of S. aureus, C. albicans and P. aerug-
inosa are represented as time-kill curves (log10 reduction
values) in Figure 1A–1H . Figure 1A–1C displays the cidal
effect of the essential oil on two strains of C. albicans (ATCC
90028 and ATCC 10231). The cidal activity was exhibited for
concentrations ranging between 0.0625% and 0.25% with
the strain ATCC 10231 being less sensitive. The candidaci-
dal activity is reflected in both methods used in this study
(UW and UI). In the UI method the minimum percentage of
inhibition (MPI) >0.125% (Figure 1B) whereas viable counts
were considerably lower at the same concentration in the
UW assay. This deviation could probably be ascribed to a
lower initial inoculum as observed at 0min for the culture
used in the UW assay (Figure 1C) compared to the UI
method (Figures 1A and 1B). At higher concentrations (0.5%
and 1%) the death kinetics show a decrease in the number
of surviving P. aeruginosa cells within 60min but the CFU’s
increased over time (Figure 1D). This suggests that the oil
produces an initial bacteriostatic effect but regrowth of the
organism occurs with time. For S. aureus the essential oil
generally follows a concentration-dependent antibacterial
activity (Figure 1E–1H). The methicillin sensitive strain of S.
aureus (Figure 1E and 1F) proved to be more sensitive on
exposure to the essential oils compared to the methicillin
resistant strains MRSA 1616 and MRSA 1639, as illustrated
in Figures 1G and 1H respectively.
Comparison of the time-kill plots for the three organisms
studied showed that the killing rate was the greatest for C.
albicans and S. aureus with initial activity followed by sub-
sequent regrowth for P. aeruginosa. These results correlate
directly with the disc diffusion results which as an initial
screening process indicated inhibition of C. albicans > S.
aureus > P. aeruginosa.
Eighty-five compounds were identified in the hydro-dis-
tilled essential oil representing 87.79% of the total composi-
tion (Table 2). The major compounds identified in the essen-
tial are pinocarvone (11.13%), trans-pinocarveol (19.57%),
limonene (6.09%), trans-p-menth-1-(7)-8-diene-2-ol (7.43%)
and cis-p-menth-1-(7)-8-diene-2-ol (6.76%). This is the first
comprehensive report on the essential oil chemistry of this
important medicinal plant and these results could not cor-
roborate the oil composition reported by Da Cunha (1974)
and Gibbs (1974). The results however correspond to the
analysis reported by Chagonda et al. (1999) who also
recorded trans-pinocarveol and pinocarvone as major con-
stituents. Although no variation was recorded within a popu-
lation, more plant populations representing the wide geo-
graphical distribution range of this plant need to be analysed
to determine if various chemotypes are involved.
With reference to terpinen-4-ol Chalchat et al. (1997)
expresses caution at directly correlating antimicrobial activi-
ty to the action of the major essential oil compounds. It is,
however, interesting to tentatively correlate the observed
antimicrobial activity to essential oil composition as activity
has been reported for essential oils accumulating the same
terpenoids found in M. flabellifolius. Pinocarvone is one of
the major constituents of Hyssop oil (Hyssopus officinalis)
which is a popular home-remedy with bactericidal properties
(Kerrola et al. 1994). Sagrero-Nieves and Bartley (1995)
reported trans-pinocarveol as a major constituent (27%) in
the essential oil of Chenopodium ambrosioides. Kishore et
al. (1993) found the essential oil of the latter species to be
fungitoxic against several dermatophytes while Lall and
Meyer (1999) reported the acetone extract of Chenopodium
ambrosioides to be active against resistant strains of
Mycobacterium tuberculosis. Structure-activity relationships
are continually being investigated for essential oil com-
pounds (Hinou et al. 1989, Griffin et al. 1999). The latter
study illustrates the antimicrobial activity for bicyclic ter-
penoids (e.g. myrtenol) mentioning that the ketone is less
active than the corresponding alcohol. In an attempt at relat-
ing structure to the recorded antimicrobial activity, it is of
interest that M. flabellifolius accumulates two oxygenated
bicyclic terpenoids with the alcohol trans-pinocarveol being
present in higher quantities than the corresponding ketone,
pinocarvone. Hinou et al. (1989) also reports that the trans-
isomers are more active than the corresponding cis-isomers.
Myrothamnus flabellifolius has been used traditionally to
treat various ailments, which may be caused by bacterial or
fungal infections (for a summary of the recorded uses in
Africa see Neuwinger (2000)). As the leaves are mostly used
in these herbal preparations it is possible that the essential
oils could be responsible for the medicinal properties
ascribed to M. flabellifolius. The essential oil yield was cal-
culated at 0.04% wet wt. It is noteworthy that the essential
oil exhibited antimicrobial properties as concentrations
<0.04% (v/v). The volatile constituents (mono- and
sesquiterpenoids) will also be released and absorbed during
rituals in which the smoke from the burnt leaves is inhaled.
Cryptococcosis is a chronic infection involving mainly the
lungs and meninges and A. niger is implicated in bron-
chopulmonary lung infections (Boyd and Hoerl 1981). Both
C. neoformans and A. niger show marked antimicrobial
activity as indicated in Table 1. It is interesting to note that
trans-pinocarveol, the major essential oil component in M.
flabellifolius, is used in pharmaceutical preparations such as
OzopulminTM to treat respiratory tract disorders including
asthma. Pseudomonas aeruginosa is an opportunistic
pathogen, which may be responsible for a vast number of
nosocomial infections, in particular burn patients.
Myrothamnus flabellifolius is traditionally used as a dressing
for burns and wounds. The oil was not found to be active in
vitro against the specific strain of P. aeruginosa. Candida
albicans was selected for an in-depth fungal time-kill inves-
tigation due to its moderate antimicrobial susceptibility as
presented in the disc diffusion assay (Table 1) but more due
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Table 1: Results of the disc diffusion assay of Myrothamnus flabel-
lifolious essential oils. The diameter of the zone of inhibition is
expressed in mm including the disc (6mm). Neomycin and nystatin
served as controls for bacteria and fungi respectively
Test Organism Zone Control
Neomycin Nystatin
Pseudomonas aeruginosa 8 8 –
Escherichia coli 12 16 –
Staphylococcus aureus 12 20 –
Enterococcus faecalis 10 14 –
Proteus vulgaris 10 18 –
Serratia odorifera 12 18 –
Salmonella typhimurium 6 14 –
Candida albicans 16 – 20
Cryptococcus neoformans 22 – 26
Aspergillus niger 26 – 26
Alternaria alternata 6 – 10
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to the prevalent pathogenesis. More than 80% of all fungal
bloodstream infections are a direct result from the Candida
species and since the eighties, there has been an explosive
rise in the rate of candidial infections (Klepser et al. 1998b).
The candidacidal activity reported here could possibly pro-
vide scientific support for the traditional use of M. flabelli-
folius for Candida-related infections (e.g. mouth and vaginal
infections). The activity of M. flabellifolius essential oil
against S. aureus was investigated because of its associa-
tion with primary infections of the skin. The traditional use of
M. flabellifolius as a dressing to treat wounds and abrasions
could also be related to the antibacterial properties illustrat-
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Figure 1: Plots of mean values for log10 of the numbers of CFU ml
-1 versus time for Myrothamnus flabellifolius essential oil (oil concentrations
expressed as a % v/v) tested on Candida albicans UI ATCC 90028 (A) UI ATCC 10231 (B) UW ATCC 10231 (C) Pseudomonas aeruginosa
UI ATCC 27853 (D) Staphylococcus aureus UI ATCC 25923 (E) UW ATCC 25923 (F) UW MRSA 1616 (G) UI MRSA 1639 (H)
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RI Compound name %1
1697 carvotanacetate 0.03
1704 γ-muurolene 0.023
1706 α-terpineol 0.25
1719 borneol 0.04
1726 germacrene D 1.13
1740 α-muurolene 0.86
1747 trans carvyl acetate 0.39
1751 carvone 1.12
1758 cis-piperitol 3.68
1773 δ-cadinene 0.75
1776 γ-cadinene 0.21
1797 p-menthyl acetophenone 0.13
1802 cuminaldehyde 0.08
1804 myrtenol 1.07
1807 perilla aldehyde 0.10
1811 trans-p-menth-1-(7)-8-diene-2-ol 7.43
1845 trans-carveol 1.27
1853 cis-calamenene 0.09
1865 isopiperitenone 0.27
1882 cis-carveol 0.20
1896 cis-p-menth-1-(7)-8-diene-2-ol 6.96
1941 α-calacorene I 0.07
1945 1,5-epoxy-salvial-4(14)-ene 0.04
1953 palustrol 0.07
1956 p-isopropyl benzaldehyde 0.06
1984 α-calacorene II 0.06
2008 caryophyllene oxide 0.08
2037 salvial-4(14)-en-1-one 0.07
2057 ledol 0.29
2069 germacrene D-4β-ol 0.07
2080 cubenol 0.26
2088 1-epi-cubenol 0.43
2104 viridiflorol 0.17
2113 cumin alcohol 0.06
2144 spathulenol 0.81
2187 T-cadinol 0.85
2209 T-muurolol 1.47
2219 δ-cadinol 0.55
2255 α-cadinol 3.00
2264 intermedeol 0.22
2273 selin-11-en-4α-ol 0.43
2324 caryophylladienol II (=caryophylla-2(12), 0.10
6(13)-dien-5α-ol)
87,79
ed for S. aureus. The antimicrobial properties, with specula-
tion on possible structure activity relationships reported here
for Myrothamnus flabellifolius essential oil, may provide
some pharmaceutical rationale for the popular traditional
use of this plant in African medicinal herbal preparations.
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